- 7028 malaria professionals are enjoying the free benefits of MalariaWorld today

Who's online
There are currently 5 users and 243 guests online.
Online users
- Events
- ric.ataide
- KleinE
- epivec
- krijnpaaijmans
News Flash
Latest Jobs
Events 2010
Recent blog posts
- Announcement: Malaria Course Ifakara 2012 (English)
- Job: Postdoctoral Fellow: Malaria transmission-blocking research (Entomologist/Malariologist)
- Job: ACT Consortium Policy Liaison Officer
- Harnessing Immunity Genes Against Plasmodium: The Series
- We thought we were down to 655.000 deaths in 2010, right?
- Job: Postdoctoral Fellow: Malaria resistance research
- Let the sun shine
- Postdoctoral Fellows: Malaria research
- Guest Editorial: Don't fake it!
- Loop mediated amplification question
"Although artemisinin and related compounds have been promising therapies since the 1980s, their low availability and high cost have greatly delayed large-scale use." "Therefore, in the late 1990s, a combination of chlorproguanil (Lapudrine) and dapsone—both low-cost drugs—known as Lapdap was introduced."